about
The role of 3 Tesla diffusion-weighted imaging in the differential diagnosis of benign versus malignant cervical lymph nodes in patients with head and neck squamous cell carcinoma.Nanomedicine--challenge and perspectives.Metabolic positron emission tomography imaging in cancer detection and therapy response.FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomesHuman papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implicationsComparison of Dynamic Contrast-Enhanced MRI and PET/CT in the Evaluation of Laryngeal Cancer After Inadequate CT ResultsClinical Applications of FDG PET and PET/CT in Head and Neck Cancer.Application of metabolic PET imaging in radiation oncology.Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck.Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.Imaging of sinonasal tumours.Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.Post-treatment appearances, pitfalls, and patterns of failure in head and neck cancer on FDG PET/CT imaging.Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy.Positron-emission tomography pitfalls related to oral prosthesis.Diagnostic performance of 18 fluorodesoxyglucose positron emission/computed tomography and magnetic resonance imaging in detecting T1-T2 head and neck squamous cell carcinoma.Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.¹⁸F-FDG PET/CT and MRI in the follow-up of head and neck squamous cell carcinoma.Advancing theranostics with tumor-targeting peptides for precision otolaryngology.CT-Guided Hookwire Placement: A Technical Innovation for Preoperative Localization of Nonpalpable Cervical Lymph NodesCD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma
P2860
Q33804844-D598231D-898A-4C8B-92E3-B64DCEEA3A3CQ34247073-3DDE75BD-90D8-4E15-9153-A560EE205847Q34786518-0B98C039-1354-4191-BE19-C19355B3251BQ35096160-FE52C209-05C6-4342-9918-E881DD1A3054Q35322315-8ED65174-F757-4932-AB26-C2271207A2B6Q35866493-4EF7E9CC-9C31-46DE-A959-400937544B34Q36078705-ECA8CD27-5145-4C98-A150-29FE3890A99BQ37314625-120569D7-EDF5-40AE-B486-A0B9BC13E5E0Q37580845-F3D4D66C-D460-4C67-8D70-20E838740947Q37870929-7EFB522F-6AC5-4CC8-BF5B-8929280135E0Q37970570-72035AD0-2321-4C22-956D-DF7C583CABF5Q38008770-9F4F7115-B2E6-4BB4-BFF6-F39EA6B85CACQ38042861-3C516CB7-1070-4539-9E14-B8DD9119AB37Q38101933-D66545C8-E01E-4C67-8FE7-49DC4E5B8CC3Q38410245-EDB4A977-893B-487C-BE07-CBE667B6E4D6Q41743777-6800CD92-F4E6-49A2-8EDE-AF66A9D6374AQ43281500-F4EC5C40-9481-4ABC-98DC-EB0F6583ED8CQ44272419-F4AB72E6-D768-4FF0-8176-728B74FF5D0BQ48296713-F270C587-FF1F-4A08-9BBF-E6997067A5F4Q50638854-1D8A0FB7-0A60-49C4-A458-FE64B436EE8EQ50870633-96BF4784-3C8F-411B-8964-72D15C7A3A25Q53119609-A0211C30-DA1D-440D-8F3B-B5198401AE44Q53206645-60CA8271-B5D5-42CE-93F7-F54BD84A074FQ55006457-66D546B9-F9BE-4DDA-BEF4-D423E72D2846Q57735623-C9AFBEBD-887D-4C5E-9213-CA071267D448Q58279330-9C943BC1-E8F1-45EF-BFA8-C770E0D25DDD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current status of FDG-PET for head and neck cancer.
@en
Current status of FDG-PET for head and neck cancer.
@nl
type
label
Current status of FDG-PET for head and neck cancer.
@en
Current status of FDG-PET for head and neck cancer.
@nl
prefLabel
Current status of FDG-PET for head and neck cancer.
@en
Current status of FDG-PET for head and neck cancer.
@nl
P356
P1476
Current status of FDG-PET for head and neck cancer.
@en
P2093
Richard J Wong
P304
P356
10.1002/JSO.21018
P577
2008-06-01T00:00:00Z